RavenQuest Engages Link Media LLC to Provide Market Awareness to the USA Market

ID: 1542223
recent pressrelease next pressrelease

(businesspress24) - RavenQuest Engages Link Media LLC to Provide Market Awareness to the USA Market

October 5, 2018, Vancouver, British Columbia: RavenQuest BioMed Inc. (the Company or RavenQuest) - (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) RavenQuest BioMed Inc. has retained Link Media LLC to provide communications and market awareness services aimed at maintaining and building the profile of the Company among existing and potential shareholders.

Link Media will arrange and disseminate independent third-party research articles. The Company will retain editorial control of any materials that are published to ensure that information is consistent with the Companys public disclosure filings.

Link Media is an arms-length service provider to the Company and will be paid $150,000 in consideration for the provision of services to the Company. To the knowledge of the Company, Link Media does not own any of the Companys securities.

Our organization recognizes the importance of sharing our unique story with the investing public throughout the United States and has engaged Link Media to this end. We are committed to sharing information about our Company in a factual, prudent and realistic manner which is consistent with our in-house corporate messaging. Its important for us to remain transparent in our marketing activities and ensure any third-party medium delivers our message in an appropriate manner. We will do just that for the duration of our engagement with Link Media said George Robinson, CEO of the Company.

About RavenQuest BioMed Inc.

RavenQuest BioMed Inc. is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with Montreals McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant. The Company focuses on partnerships with Indigenous communities.



On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.

George Robinson
Chief Executive Officer

For further information, please contact:
Mathieu McDonald, Corporate Communications - 604-484-1230

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Cautionary Note Regarding Forward-Looking Statements

All statements in this press release, other than statements of historical fact, are forward-looking information with respect to the Company within the meaning of applicable securities laws, including statements with respect to the publishing and distribution of information on behalf of the Company. The Company provides forward-looking statements for the purpose of conveying information about current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. These risks and uncertainties include but are not limited to those identified and reported in the Companys public filings under the Companys SEDAR profile at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise unless required by law.




More information:
http://



Keywords (optional):



Company information / Profile:

PressRelease by

Requests:





PressContact / Agency:



published by: irw
print pressrelease  send to a friend  

Date: 10/05/2018 - 06:26
Language: English
News-ID 1542223
Character count: 4579
Kontakt-Informationen:
Firma: RavenQuest Biomed Inc.
Ansprechpartner: Feedback to businesspress24.com about Pressrelease-id:
Stadt: Wien
Telefon:

Meldungsart:
Versandart:
Freigabedatum:
Comments:



Number of hits: 164

Linking-Tips:



Direct Link to this PressRelease:






We would appreciate a link in your News-, Press- or Partner-Site.

Comments on this PressRelease






All members: 8 804
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 71


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.

Categories:


[ more PressReleases ][ RSS-Feed ]